Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

NVV1 chart

Key stats

Market capitalization
‪521.58 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.955EUR
Net income
‪−493.83 M‬EUR
Revenue
‪891.25 M‬EUR
Shares float
‪132.98 M‬
Beta (1Y)
1.42

About NOVAVAX INC

Sector
Health Technology
Industry
Biotechnology
CEO
John C.s Jacobs
Website
novavax.com
Headquarters
Gaithersburg
Employees (FY)
‪1.54 K‬
Founded
1987
FIGI
BBG000TL7M50
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where NVV1 is featured.

See all sparks 

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange NOVAVAX INC stocks are traded under the ticker NVV1.
NOVAVAX INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
NVV1 earnings for the last quarter are −1.19 EUR per share, whereas the estimation was −2.10 EUR resulting in a 43.12% surprise. The estimated earnings for the next quarter are −0.41 EUR per share. See more details about NOVAVAX INC earnings.
NOVAVAX INC revenue for the last quarter amounts to ‪176.89 M‬ EUR despite the estimated figure of ‪109.19 M‬ EUR. In the next quarter revenue is expected to reach ‪291.78 M‬ EUR.
Yes, you can track NOVAVAX INC financials in yearly and quarterly reports right on TradingView.
NVV1 net income for the last quarter is ‪−161.62 M‬ EUR, while the quarter before that showed ‪−123.71 M‬ EUR of net income which accounts for −30.64% change. Track more NOVAVAX INC financial stats to get the full picture.
No, NVV1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NVV1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVAVAX INC stock right from TradingView charts — choose your broker and connect to your account.
NVV1 reached its all-time high on Feb 9, 2021 with the price of 274.950 EUR, and its all-time low was 3.220 EUR and was reached on Nov 21, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has ‪1.54 K‬ employees. See our rating of the largest employees — is NOVAVAX INC on this list?
We've gathered analysts' opinions on NOVAVAX INC future price: according to them, NVV1 price has a max estimate of 34.80 EUR and a min estimate of 3.66 EUR. Read a more detailed NOVAVAX INC forecast: see what analysts think of NOVAVAX INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVAVAX INC EBITDA is ‪−462.70 M‬ EUR, and current EBITDA margin is −38.00%. See more stats in NOVAVAX INC financial statements.